Skip to main content
. 2020 Sep 22;47(1):80–85. doi: 10.1097/DSS.0000000000002795

TABLE 3.

Common Treatment-Related Adverse Events (AEs) After Initial/Touch-Up Treatment

Event, n Onset (d) Duration (d) Severity Resolution
Injection site abscess 6 9 Moderate Resolved w/o sequelae
Gingival pain 1 2 Moderate Resolved w/o sequelae
Acne cystic 6 134 Mild Resolved w/o sequelae
Injection site cellulitis 7 36 Severe Resolved w/o sequelae
Injection site inflammation 7 153 Severe Resolved w/o sequelae

w/o, without.